352 related articles for article (PubMed ID: 34031129)
1. The Host Cellular Immune Response to Infection by Campylobacter Spp. and Its Role in Disease.
Callahan SM; Dolislager CG; Johnson JG
Infect Immun; 2021 Jul; 89(8):e0011621. PubMed ID: 34031129
[TBL] [Abstract][Full Text] [Related]
2. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
3. Update on human Campylobacter jejuni infections.
Kirkpatrick BD; Tribble DR
Curr Opin Gastroenterol; 2011 Jan; 27(1):1-7. PubMed ID: 21124212
[TBL] [Abstract][Full Text] [Related]
4. The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases.
Phongsisay V
Immunobiology; 2016 Apr; 221(4):535-43. PubMed ID: 26709064
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.
Kaakoush NO; Deshpande NP; Man SM; Burgos-Portugal JA; Khattak FA; Raftery MJ; Wilkins MR; Mitchell HM
Infect Immun; 2015 Feb; 83(2):832-45. PubMed ID: 25486993
[TBL] [Abstract][Full Text] [Related]
6. Glycoconjugates play a key role in Campylobacter jejuni Infection: interactions between host and pathogen.
Day CJ; Semchenko EA; Korolik V
Front Cell Infect Microbiol; 2012; 2():9. PubMed ID: 22919601
[TBL] [Abstract][Full Text] [Related]
7. Campylobacter jejuni-mediated disease pathogenesis: an update.
Zilbauer M; Dorrell N; Wren BW; Bajaj-Elliott M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):123-9. PubMed ID: 18023831
[TBL] [Abstract][Full Text] [Related]
8. The chronic gastrointestinal consequences associated with campylobacter.
Riddle MS; Gutierrez RL; Verdu EF; Porter CK
Curr Gastroenterol Rep; 2012 Oct; 14(5):395-405. PubMed ID: 22864805
[TBL] [Abstract][Full Text] [Related]
9. Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries.
Schnee AE; Petri WA
Curr Opin Infect Dis; 2017 Jun; 30(3):322-328. PubMed ID: 28157786
[TBL] [Abstract][Full Text] [Related]
10. Oxidative and nitrosative stress defences of Helicobacter and Campylobacter species that counteract mammalian immunity.
Flint A; Stintzi A; Saraiva LM
FEMS Microbiol Rev; 2016 Nov; 40(6):938-960. PubMed ID: 28201757
[TBL] [Abstract][Full Text] [Related]
11. Campylobacter, from obscurity to celebrity.
Butzler JP
Clin Microbiol Infect; 2004 Oct; 10(10):868-76. PubMed ID: 15373879
[TBL] [Abstract][Full Text] [Related]
12. Campylobacter jejuni.
Fields PI; Swerdlow DL
Clin Lab Med; 1999 Sep; 19(3):489-504, v. PubMed ID: 10549422
[TBL] [Abstract][Full Text] [Related]
13. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.
Tribble DR; Baqar S; Carmolli MP; Porter C; Pierce KK; Sadigh K; Guerry P; Larsson CJ; Rockabrand D; Ventone CH; Poly F; Lyon CE; Dakdouk S; Fingar A; Gilliland T; Daunais P; Jones E; Rymarchyk S; Huston C; Darsley M; Kirkpatrick BD
Clin Infect Dis; 2009 Nov; 49(10):1512-9. PubMed ID: 19842970
[TBL] [Abstract][Full Text] [Related]
14. Interaction between Campylobacter and intestinal epithelial cells leads to a different proinflammatory response in human and porcine host.
Aguilar C; Jiménez-Marín Á; Martins RP; Garrido JJ
Vet Immunol Immunopathol; 2014 Nov; 162(1-2):14-23. PubMed ID: 25307769
[TBL] [Abstract][Full Text] [Related]
15. Treatment with the Probiotic Product Aviguard
Heimesaat MM; Weschka D; Mousavi S; Bereswill S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206478
[TBL] [Abstract][Full Text] [Related]
16. [Campylobacteriosis].
Polák P; Juránková J; Husa P
Klin Mikrobiol Infekc Lek; 2014 Jun; 20(2):50-4. PubMed ID: 25135140
[TBL] [Abstract][Full Text] [Related]
17. Avian resistance to Campylobacter jejuni colonization is associated with an intestinal immunogene expression signature identified by mRNA sequencing.
Connell S; Meade KG; Allan B; Lloyd AT; Kenny E; Cormican P; Morris DW; Bradley DG; O'Farrelly C
PLoS One; 2012; 7(8):e40409. PubMed ID: 22870198
[TBL] [Abstract][Full Text] [Related]
18. The clinical importance of emerging Campylobacter species.
Man SM
Nat Rev Gastroenterol Hepatol; 2011 Oct; 8(12):669-85. PubMed ID: 22025030
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of peripheral blood lymphocytes with Campylobacter jejuni generates a gammadelta T cell response in patients with Guillain-Barrésyndrome.
Ben-Smith A; Goodall JC; Gaston JS; Winer JB
Clin Exp Immunol; 1997 Jul; 109(1):121-6. PubMed ID: 9218834
[TBL] [Abstract][Full Text] [Related]
20. Role of putative virulence traits of Campylobacter jejuni in regulating differential host immune responses.
Singh A; Mallick AI
J Microbiol; 2019 Apr; 57(4):298-309. PubMed ID: 30796746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
